February 6th 2025
Nanette Silverberg, MD, highlights new dermatology advancements and the significance of conferences like MOPD in shaping the future of treatment.
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Revolutionizing Atopic Dermatitis (RAD) Conference 2025
June 6-7, 2025
Register Now!
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis
View More
Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?
View More
How can we reconcile the spirit of the law with the letter of the law?
December 1st 2012I am inherently skeptical of rules. But I also appreciate their potential value. Many rules are good and intended to ensure societal order, support justice and minimize error. I'm especially a fan of well-designed rules intended to control the strong personal gain incentive. But complex rules incorporate details that the devil loves to manipulate.
Patch testing often is underused for identifying contact dermatitis cause
October 1st 2012Although contact dermatitis is more widely recognized in children, patch testing - the gold standard for identification of the condition - is underutilized in this population, says Sharon E. Jacob, M.D., associate clinical professor of medicine and pediatrics, University of California, San Diego.
Atopic dermatitis often presents differently in children with skin of color
October 1st 2012Atopic dermatitis presents differently in children with skin of color, and dermatologists should be aware and culturally sensitive when managing the disease in these patients, says Adelaide A. Hebert, M.D., professor of dermatology and pediatrics, University of Texas Medical School at Houston.
Treatment advances target vitiligo, periorificial dermatitis in children of color
October 1st 2012In treating children of color, promising breakthroughs include the discovery that nutritional deficiencies may have implications in vitiligo, said Nanette Silverberg, M.D., at the 2012 American Academy of Dermatology Summer Academy Meeting.
Multiple modalities enable successful treatment of atopic dermatitis in children
September 1st 2012Topical corticosteroids are still the mainstay of therapy for pediatric atopic dermatitis (AD), but dermatologists have an array of other options at their disposal to use for steroid sparing or in challenging situations.
Nutritional deficiencies may precipitate vitiligo in children of color
August 21st 2012Promising breakthroughs in treating children of color include the discovery that nutritional deficiencies may have implications in vitiligo, said Nanette Silverberg, M.D., at the 2012 American Academy of Dermatology Summer Academy Meeting.
Compiling baffling medical encounters proves a great way to cope
August 1st 2012We medical professionals are confronted with our own assortment of believe-it-or-nots and oddities on a daily basis. Unfortunately, they are often more upsetting or frustrating than astounding. I started keeping a list a few years ago, initially as a coping mechanism. But gradually, the list evolved into a collection.
Parents favor consent for kids' HPV vaccines
July 25th 2012Most adults in the U.S. support laws allowing teenagers access to medical care for sexually transmitted infections without parental consent, but they want parents to decide whether their child should get the human papillomavirus (HPV) vaccine, a recent nationwide survey suggests.
Suspected melanonychia in pediatric patients can confound physicians
June 1st 2012Differentiating benign nail pigmentations such as melanonychia from either nail or nail matrix melanoma is especially difficult in children because pediatric lesions present differently than they do in adults, according to Antonella Tosti, M.D., professor of the department of dermatology and cutaneous surgery, University of Miami Miller School of Medicine.
Dermatology Times adds new member to Editorial Advisory Council
June 1st 2012Dermatology Times welcomes Albert C. Yan, M.D., as the newest member to its Editorial Advisory Council. Dr. Yan is the chief of pediatric dermatology at Children's Hospital of Philadelphia, where he is also an associate professor of pediatrics and dermatology at the Perelman School of Medicine at the University of Pennsylvania.
Propranolol combined with PDL clears infantile hemangioma
June 1st 2012The combined use of propranolol and pulsed dye laser (PDL) resulted in more rapid and complete clearance of infantile hemangiomas than propranolol monotherapy, according to data presented at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.
Propranolol and PDL clear infantile hemangiomas
April 24th 2012The use of propranolol and pulsed dye laser (PDL) led to more rapid clearing of infantile hemangiomas than propranolol alone, according to a retrospective chart review presented at the 2012 annual meeting of the American Society for Laser Medicine and Surgery.
Off-label treatment with biologics effective for treating certain skin diseases
February 1st 2012Biologic drugs have proven to be of benefit for diseases where there is no indicated treatment, such as for immunobullous diseases. "Pemphigus vulgaris with rituximab (Rituxan, Genentech) has been a major advance, although this is not a formally approved indication for the drug," says Alan Menter, M.D., chief, dermatology, and chairman, residency program, Baylor University Medical Center, Dallas.
Infants with severe atopic dermatitis require team approach
February 1st 2012The unique needs of infants with severe atopic dermatitis require special attention. As such, says Mary Wu Chang, M.D., associate clinical professor of dermatology and pediatrics, University of Connecticut School of Medicine, "This is not something you can handle in a 15-minute visit."
Segmental pigmentation not associated with systemic manifestations, study finds
September 1st 2011Although patterned pigmentation in children can include a variety of clinical findings involving neurologic, musculoskeletal and cardiac abnormalities, most localized pigmentary disorders are not associated with systemic manifestations, according to pediatric dermatologist James Treat, M.D., University of Pennsylvania School of Medicine, Philadelphia.
Pediatric literature gives insight on new therapies for children
September 1st 2011Recent publications in pediatric literature are driving practice changes relative to conditions ranging from Kawasaki disease to child abuse to hemangiomas. Perhaps the most important recent pediatric publication many dermatologists may have missed addresses evaluating abuse versus accidental trauma in infants and young children, says Robert Sidbury, M.D., M.P.H., chief of pediatric dermatology and associate professor of pediatrics, Seattle Children's Hospital.